Kevin Outterson
Kevin Outterson | |
|---|---|
| Alma mater | Northwestern University University of Reading |
| Occupation | Law professor |
| Employer | Boston University School of Law |
| Known for | Health Law, Intellectual Property Law, Antibiotic Resistance |
Kevin Outterson is a lawyer, and the N. Neal Pike Scholar in Health and Disability Law at Boston University (2014–present). He is also the Executive Director of CARB-X|Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X),[1] a global non-profit partnership focused on development of antibiotics, diagnostics, vaccines and other products for drug-resistant bacterial infections. His work focuses primarily on law and economics of antibiotic resistance, health law, intellectual property, and global access to medicine.[1]
Outterson has testified before Congress, the World Health Organization (WHO), and various state legislatures.[2][which?]
He is Co-director of the health law program at Boston University School of Law (2007–present) and associate fellow at the Royal Institute of International Affairs at Chatham House, London (2014–present). He served on the Board of the American Society of Law, Medicine & Ethics, and serves as faculty editor to the American Journal of Law & Medicine (2007–present). He is past editor-in-chief of the Journal of Law, Medicine & Ethics (2010–2016).[1]
References[]
- ^ Jump up to: a b c "Kevin Outterson | School of Law". www.bu.edu. Retrieved 12 May 2020.
- ^ "Professor Kevin Outterson". Chatham House. Retrieved 2020-05-01.
External links[]
- Kevin Outterson publications indexed by Google Scholar
| hide Authority control  | |
|---|---|
| General | |
| National libraries | |
  | This American law–related biographical article is a stub. You can help Wikipedia by . |
- Living people
- Boston University faculty
- American lawyers
- Northwestern University alumni
- Medical journal editors
- American jurist stubs